Infusive Asset Management’s Nike NKE Stock Holding History

Infusive Asset Management’s Portfolio NKE Stock Details NKE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-140,200	Closed	-$20.4M	–	50
2021 Q3	$20.4M	Buy	+140,200	New	+$22.9M	4.34%	11

Other funds holding NKE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Infusive Asset Management's NKE Position: Q3 2025 in Review

Infusive Asset Management sold out of Nike (NKE) in Q3 2025, closing a stake of 27,211 shares — an estimated $1.93M sold.

Infusive Asset Management first reported a position in NKE in Q4 2020 and held it in 19 quarters. The position peaked at $21.2M in Q3 2021. 2,057 funds tracked by Wall St. Rank hold NKE as of Q3 2025.

Infusive Asset Management reported no remaining Nike position as of Q3 2025 after selling out during the quarter.
Infusive Asset Management sold 27,211 Nike shares in Q3 2025, an estimated $1.93M.
Infusive Asset Management first reported a position in Nike in Q4 2020 and held it in 19 quarters.
Infusive Asset Management's Nike position peaked at $21.2M in Q3 2021.
2,057 funds tracked by Wall St. Rank held Nike as of Q3 2025.

Based on Infusive Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.